We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
1001
DELISTED
Adverum Biotechnologies
ADVM
$290K 0.01%
24,200
– –
USCB icon
1002
USCB Financial Holdings
USCB
$410M
$289K 0.01%
25,000
– –
TRVI icon
1003
Trevi Therapeutics
TRVI
$2.63B
$288K 0.01%
102,600
+27,600
+37% +$67.8K
ABBV icon
1004
AbbVie
ABBV
$431B
$285K 0.01%
1,859
– –
CVR icon
1005
Chicago Rivet & Machine Co
CVR
$10M
$285K 0.01%
10,000
– –
TAIT
1006
DELISTED
Taitron Components
TAIT
$285K 0.01%
78,200
-300
-0.4% -$1.09K
TCRR
1007
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$285K 0.01%
98,400
– –
AIRT icon
1008
Air T
AIRT
$92.2M
$284K 0.01%
17,250
– –
PJT icon
1009
PJT Partners
PJT
$4.42B
$281K 0.01%
4,000
– –
SCYX icon
1010
SCYNEXIS
SCYX
$51.6M
$281K 0.01%
18,875
+9,312
+97% +$179K
NTIC icon
1011
Northern Technologies International Corp
NTIC
$77.8M
$279K 0.01%
29,800
– –
SPRY icon
1012
ARS Pharmaceuticals
SPRY
$551M
$279K 0.01%
65,800
-36,900
-36% -$129K
GIFI
1013
DELISTED
Gulf Island Fabrication
GIFI
$278K 0.01%
83,048
+65,000
+360% +$229K
AIOT
1014
PowerFleet Inc
AIOT
$554M
$277K 0.01%
127,700
+24,000
+23% +$61K
TILE icon
1015
Interface
TILE
$2.04B
$272K 0.01%
21,700
-136,800
-86% -$1.81M
XGN icon
1016
Exagen
XGN
$160M
$272K 0.01%
47,300
-27,700
-37% -$161K
VIRX
1017
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$272K 0.01%
70,000
– –
TIG
1018
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$272K 0.01%
+43,600
New +$259K
CABA icon
1019
Cabaletta Bio
CABA
$450M
$270K 0.01%
254,552
+132,222
+108% +$187K
SRTS icon
1020
Sensus Healthcare
SRTS
$49.1M
$270K 0.01%
+35,100
New +$295K
WLMS
1021
DELISTED
Williams Industrial Services Group Inc.
WLMS
$270K 0.01%
194,500
+13,300
+7% +$21.6K
DXYN
1022
DELISTED
Dixie Group Inc
DXYN
$269K 0.01%
210,200
– –
SONX
1023
DELISTED
Sonendo, Inc.
SONX
$269K 0.01%
156,500
+71,500
+84% +$191K
ANVS icon
1024
Annovis Bio
ANVS
$79.1M
$268K 0.01%
23,600
– –
KPLT icon
1025
Katapult Holdings
KPLT
$32.1M
$268K 0.01%
+10,016
New +$396K
39 40
41
42 43

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.